Southwestern Medical Solutions, Inc. (SWNM) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerSouthwestern Medical Solutions, Inc. (SWNM) trades at $0.00003. Southwestern Medical Solutions, Inc. focuses on researching and developing medical devices, specifically a point-of-care diagnostic tool. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for SWNM: SWNM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Southwestern Medical Solutions, Inc. (SWNM) Healthcare & Pipeline Overview
Southwestern Medical Solutions, Inc. is a medical device company specializing in the research, development, and potential commercialization of point-of-care diagnostic solutions. Their LabGuard Accucheck device targets the on-site diagnostic testing and screening market, positioning them within the broader healthcare diagnostics industry.
What Is the Investment Thesis for SWNM?
Investing in Southwestern Medical Solutions, Inc. presents a high-risk, high-reward scenario. The company's success hinges on the successful development, regulatory approval, and commercialization of its LabGuard Accucheck device. As of 2026, the company has a market capitalization of $0.00B and operates with a beta of -103.33, indicating extreme volatility. Key value drivers include securing regulatory clearances, establishing manufacturing capabilities, and achieving market penetration. Growth catalysts depend on positive clinical trial data (if applicable), strategic partnerships, and successful market adoption. However, potential risks include the company's OTC listing, limited financial resources, and intense competition in the medical device industry.
Based on FMP financials and quantitative analysis
SWNM Key Highlights
Southwestern Medical Solutions, Inc. is focused on the research and development of medical devices.
- The company's primary product is LabGuard Accucheck, a device for on-site diagnostic testing and screening.
- The company was incorporated in 2003 and is based in Tampa, Florida.
- The company has a market capitalization of $0.00B as of March 17, 2026.
- The company operates with a beta of -103.33, indicating extreme volatility.
Who Are SWNM's Competitors?
SWNM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BJDX Bluejay Diagnostics, Inc. | $0.84 | -1.12% | 30 5-pillar | |
| NVNO enVVeno Medical Corporation | $8.10 | +0.75% | $5.63M | 33 5-pillar |
| BDMD Baird Medical Investment Holdings Limited | $0.75 | +0.91% | $31.7M | — |
| SNWV SANUWAVE Health, Inc. | $4.82 | +4.33% | $41.5M | 36 5-pillar |
| SRTS Sensus Healthcare, Inc. | $2.98 | +1.02% | $49.1M | 31 5-pillar |
| HYPD Hyperion DeFi, Inc. | $3.73 | +1.91% | $56.5M | 36 5-pillar |
| LNSR LENSAR, Inc. | $6.75 | +2.74% | $82.9M | 45 5-pillar |
| APYX Apyx Medical Corporation | $2.55 | +2.00% | $107M | 33 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SWNM's Key Strengths?
Proprietary LabGuard Accucheck technology.
- Focus on the growing point-of-care diagnostics market.
- Potential for rapid diagnostic results.
- Experienced leadership team.
What Are SWNM's Weaknesses?
Limited financial resources.
- Dependence on a single product.
- Lack of established distribution channels.
- OTC listing indicates higher risk.
What Are the Key Risks for SWNM?
Failure to obtain regulatory approvals for LabGuard Accucheck.
- Competition from established medical device companies.
- Technological obsolescence.
- Limited financial resources.
- OTC listing indicates higher risk and potential for fraud.
What Threats Does SWNM Face?
- Intense competition from established medical device companies.
- Stringent regulatory requirements.
- Technological obsolescence.
- Product liability risks.
What Are SWNM's Competitive Advantages?
- Proprietary technology in the LabGuard Accucheck device.
- Potential for intellectual property protection through patents.
- First-mover advantage in the on-site diagnostic testing market.
- Established relationships with healthcare providers and research institutions.
What Does SWNM Do?
Southwestern Medical Solutions, Inc., founded in 2003 and based in Tampa, Florida, is a medical device company focused on the research and development of innovative diagnostic solutions. The company's core product is the LabGuard Accucheck, a device designed for on-site collection, analysis, and testing of samples. This device aims to provide rapid results for the on-site diagnostic testing and screening market, potentially streamlining diagnostic processes and improving patient outcomes. The company's focus is on developing and potentially commercializing the LabGuard Accucheck device. The company aims to address the growing need for rapid and accessible diagnostic testing. By offering a device that can perform on-site analysis, Southwestern Medical Solutions, Inc. seeks to reduce the time and complexity associated with traditional laboratory testing. The company's operations are currently centered around the development and potential market introduction of this technology.
What Products and Services Does SWNM Offer?
- Researches and develops medical devices.
- Offers LabGuard Accucheck, a device for on-site collection and analysis.
- Provides testing to deliver results for the on-site diagnostic testing/screening market.
- Aims to streamline diagnostic processes and improve patient outcomes.
- Focuses on point-of-care diagnostic solutions.
- Seeks to reduce the time and complexity associated with traditional laboratory testing.
How Does SWNM Make Money?
- Develops and commercializes medical devices for diagnostic testing.
- Generates revenue through the sale of LabGuard Accucheck devices.
- Potentially generates revenue through service contracts and reagent sales.
- May explore licensing agreements or strategic partnerships for further revenue streams.
What Industry Does SWNM Operate In?
Southwestern Medical Solutions, Inc. operates within the medical device industry, a sector characterized by rapid innovation and stringent regulatory requirements. The competitive landscape includes established players with extensive product portfolios and smaller, specialized companies focused on niche markets. Competitors include ABMT (ABIOMED, Inc.), ACNV (Accenvion, Inc.), AHGIF (AHG International, Inc.), CEVE (Celvive Bioscience, Inc.), and CGHC (China Green Healthcare Group, Inc.).
Who Are SWNM's Key Customers?
- Hospitals and clinics seeking on-site diagnostic testing solutions.
- Healthcare providers looking to improve patient outcomes through rapid diagnostics.
- Laboratories seeking to streamline their testing processes.
- Research institutions conducting clinical trials and studies.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Southwestern Medical Solutions, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Tampa, US. The company is led by CEO John R. Hedges. SWNM has traded publicly since 2000.
SWNM Financials
SWNM Latest News
No recent news available for SWNM.
SWNM Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SWNM.
Price Targets
Wall Street price target analysis for SWNM.
SWNM MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for SWNM; grades run from A+ (80-100) to F (below 30).
Leadership: John R. Hedges
CEO
John R. Hedges serves as the Chief Executive Officer of Southwestern Medical Solutions, Inc. His leadership is focused on guiding the company through the research, development, and potential commercialization phases of its LabGuard Accucheck device.
Track Record: Information regarding John R. Hedges' specific achievements and strategic decisions as CEO of Southwestern Medical Solutions, Inc. is not available in the provided data. Therefore, a comprehensive assessment of his track record cannot be made.
SWNM OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Southwestern Medical Solutions, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries a significantly higher risk compared to those listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited financial disclosure increases information asymmetry.
- Low trading volume and wide bid-ask spreads can lead to illiquidity.
- Higher risk of fraud or manipulation due to less regulatory oversight.
- Potential for delisting or suspension of trading.
- Shell risk detected, indicating potential for fraudulent activity.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's intellectual property and technology.
- Determine the company's capital structure and debt levels.
- Investigate any legal or regulatory issues involving the company.
- Consult with a qualified financial advisor before investing.
- The company has been in operation since 2003.
- The company is focused on developing a specific medical device (LabGuard Accucheck).
- The company is based in Tampa, Florida.
- The company has a CEO, John R. Hedges.
Southwestern Medical Solutions, Inc. Healthcare Stock: Key Questions Answered
What do analysts say about SWNM stock?
As of March 17, 2026, there is no available analyst coverage for Southwestern Medical Solutions, Inc. given its OTC listing and limited market capitalization. Key valuation metrics are difficult to assess due to the company's early stage of development and lack of revenue generation.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is limited due to the company's OTC listing and limited financial disclosure.
- The company's future performance is highly dependent on the successful development and commercialization of LabGuard Accucheck.